ACA
DXCM icon

Aptus Capital Advisors’s DexCom DXCM Stock Holding History

Aptus Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,074
Closed -$270K – 1704
2025
Q4 		$270K Buy
4,074
+932
+30% +$60.3K ﹤0.01% 923
2025
Q3 		$211K Sell
3,142
-1,025
-25% -$81.1K ﹤0.01% 962
2025
Q2 		$364K Buy
4,167
+1,202
+41% +$94.2K ﹤0.01% 768
2025
Q1 		$202K Sell
2,965
-118
-4% -$9.63K ﹤0.01% 890
2024
Q4 		$240K Buy
+3,083
New +$228K ﹤0.01% 835
2024
Q3 		– Sell
-2,949
Closed -$334K – 1244
2024
Q2 		$334K Buy
2,949
+263
+10% +$33.3K 0.01% 591
2024
Q1 		$373K Buy
2,686
+665
+33% +$83.6K 0.01% 576
2023
Q4 		$251K Buy
+2,021
New +$206K 0.01% 496

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aptus Capital Advisors's DXCM Position: Q1 2026 in Review

Aptus Capital Advisors sold out of DexCom (DXCM) in Q1 2026, closing a stake of 4,074 shares — an estimated $270K sold.

Aptus Capital Advisors first reported a position in DXCM in Q4 2023 and held it in 8 quarters. The position peaked at $373K in Q1 2024. 962 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Aptus Capital Advisors reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Aptus Capital Advisors sold 4,074 DexCom shares in Q1 2026, an estimated $270K.
  • Aptus Capital Advisors first reported a position in DexCom in Q4 2023 and held it in 8 quarters.
  • Aptus Capital Advisors's DexCom position peaked at $373K in Q1 2024.
  • 962 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.